Abstract
Background Social distancing measures to address the U.S. COVID-19 epidemic may have significant health, social, and economic impacts.
Methods We conducted an interrupted time-series analysis to estimate the mean change in state-level COVID-19 epidemic growth before versus after the implementation of statewide social distancing measures. Our primary exposure was time (in days) before versus after implementation of the first statewide social distancing measure. The pre-implementation period began 14 days prior to implementation and continued up to 3 days after implementation to account for incubation. Post-implementation began 4 days after, up to and including March 30. Our primary outcome was the COVID-19 growth rate, calculated as the log of daily COVID-19 cases minus the log of daily COVID-19 cases on the prior day.
Results All states applied some form of statewide social distancing between March 10-27. The mean daily COVID-19 growth rate decreased beginning four days after implementation of the first statewide social distancing measures, by an additional 0.8% per day; 95% CI, -1.4% to -0.2%; P=0.002). This reduction corresponds to an increase in doubling time of the epidemic from 3.3 days (before) to 5.0 days (at 14 days after implementation). Our study is subject to potential bias due to the aggregate nature of the ecological data, potential confounding by contemporaneous changes (e.g., increases in testing), and potential underestimation of social distancing due to spillover effects across neighboring states.
Conclusion Statewide social distancing measures were associated with a decrease in U.S. COVID-19 epidemic growth. Based on the size of the epidemic at the time of implementation in each state, social distancing measures were associated with a decrease of 3,090 cases at 7 days, and 68,255 cases at 14 days, after implementation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GH is supported by a fellowship from the Royal Society and the Wellcome Trust (210479/Z/18/Z)
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data will be available through public databases and the supplementary materials.
